Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 910-757-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 September 2009 to 20 October 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP-study according to OECD guideline 429
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Date of GLP inspection: 2009-11-26 Date of signature: 26-11-2009
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction mass of divinylbenzene and ethylstyrene
- EC Number:
- 910-757-7
- Cas Number:
- N/A
- Molecular formula:
- Divinylbenzene: C10H10 Ethylstyrene: C10H12
- IUPAC Name:
- Reaction mass of divinylbenzene and ethylstyrene
- Details on test material:
- Sponsor's identification : Divinylbenzene 55
Description : clear colourless liquid with black inclusions
Batch number : XF30012V44
Date received : 07 August 2009
Storage conditions : approximately 4°C in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Female CBA/Ca (CBA/CaOlaHsd) strain mice were supplied by Harlan UK Limited, Bicester, Oxon, UK. The strain of mouse used in these laboratories has been shown to produce satisfactory responses using known sensitisers and non-sensitisers during the in-house validation. The results of routine positive control studies are shown in Appendix 1 and Appendix 2. The results of the study are believed to be of value in predicting the sensitisation potential of the test material to man.
- Age at study initiation: At the start of the study the animals were eight to twelve weeks old.
- Weight at study initiation: At the start of the study the animals were in the weight range of 15 to 23g.
- Housing: The animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes. The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
- Diet (e.g. ad libitum): ad libitum (2014 Teklad Global Rodent diet supplied by Harlan Teklad, Blackthorn, Bicester, Oxon, UK)
- Water (e.g. ad libitum): ad libitum.
- Acclimation period: At least five days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): The temperature was controlled to remain within the target ranges of 19 to 25 deg C.
- Humidity (%): The humidity was controlled to remain within the target ranges of 30 to 70%.
- Air changes (per hr): The rate of air exchange was approximately fifteen changes per hour.
- Photoperiod (hrs dark / hrs light): The lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Groups of five mice were treated with the undiluted test material or the test material at concentrations of 50% or 25% v/v in acetone/olive oil 4:1.
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS: Preliminary Screening Test
Using available information regarding the systemic toxicity/irritancy potential of the test material, a preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µL of the undiluted test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Any signs of toxicity or excessive local irritation noted during this period were recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6.
Clinical observations, bodyweight and mortality data are give in the results section (table 1). No signs of systemic toxicity were noted. Based on this information the dose levels selected for the main test were 25% and 50% v/v in acetone/olive oil 4:1 and 100%.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay in the Mouse. The assay has undergone extensive inter-laboratory validation and has been shown to reliably detect test materials that are moderate to strong sensitisers.
- Criteria used to consider a positive response: The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node(dpm/node) and as the ratio of 3HTdR incorporation in lymph node cells of test nodes relative to that recorded for the control nodes (stimulation Index). The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitier".
TREATMENT PREPARATION AND ADMINISTRATION: Groups of five mice were treated with the undiluted test material or the test material at concentrations of 50% or 25% v/v in acetone/olive oil 4:1. The preliminary screening test suggested that the test material would not produce systemic toxicity or excessive local irritation at the highest suitable concentration. The mice were treated by daily application of 25 µL of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of five mice received the vehicle alone in the same manner. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical Analysis
Data was processed to give group mean values for disintegrations per minute and standard deviations where appropriate. Individual and group mean disintegrations per minute values were assessed for dose response relationships by analysis of homogeneity of variance followed by one way analysis of variance (ANOVA). In the event of a significant result from the ANOVA, pairwise comparisons were performed between control and treated groups. For homogenous datasets Dunnett’s Multiple Comparison test was used and for non homogenous datasets Dunnett’s T3 Multiple Comparison Method was used.
Probability values (p) are presented as follows:
P<0.001 ***
P<0.01 **
P<0.05 *
P>0.05 (not significant)
Results and discussion
- Positive control results:
- A study was performed to assess the sensitivity of the strain of mouse used at these laboratories to a known sensitiser. The methodology for the LLNA is detailed in the OECD Guideline for the Testing of Chemicals, No. 429, and Method B.42 of Commission Regulation (EC) No. 440/2008. The study was based on these test methods but has been refined in order to reduce the number of animals required. The reduced LLNA (rLLNA) has been endorsed by the non Commission members of the European Centre for the Validation of Alternative Method (ECVAM) Scientific Advisory Committee (ESAC) at its 26th meeting held on 26 – 27 April 2007 at ECVAM, Ispra, Italy.
Test Material: α Hexylcinnamaldehyde
Project number: 0039/1107
Study dates: 11 September 2009 to 17 September 2009
A group of five animals was treated with 50 µL (25 µL per ear) of α Hexylcinnamaldehyde as a solution in acetone/olive oil 4:1 at a concentration of 15% v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone. The control group was shared with Project Number 0673/0012.
The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group is as follows:
Concentration (% v/v) in
acetone/olive oil 4:1 Stimulation Index Result
15 3.70 Positive
Conclusion. α Hexylcinnamaldehyde was considered to be a sensitiser under the conditions of the test.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 4.09
- Test group / Remarks:
- 25%
- Remarks on result:
- other: positive
- Parameter:
- SI
- Value:
- 5
- Test group / Remarks:
- 50%
- Remarks on result:
- other: positive
- Parameter:
- SI
- Value:
- 6.78
- Test group / Remarks:
- 100%
- Remarks on result:
- other: positive
Any other information on results incl. tables
RESULTS
Preliminary Screening Test
Clinical observations, bodyweight and mortality data are given in Table 1.
No signs of systemic toxicity were noted.
Based on this information the undiluted test material and the test material at concentrations of 50% and 25% v/v in acetone/olive oil 4:1 were selected for the main test.
Main Test
Estimation of the Proliferative Response of Lymph Node Cells
The radioactive disintegrations per minute per lymph nodes for each individual animal and the stimulation index are given in Table2.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (%v/v) in |
Stimulation Index |
Result |
25 |
4.09 |
Positive |
50 |
5.00 |
Positive |
100 |
6.78 |
Positive |
Clinical Observations and Mortality Data
Individual clinical observations and mortality data for test and control animals are given in Table 3.
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
Bodyweight
Individual bodyweights and bodyweight changes for test and control animals are given in Table 4.
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
CALCULATION OF THE EXTRAPOLATED EC3VALUE
aEC3= 2^ {log2(c) + (3-d)/(b-d)] x [log2(a)-log2(c)]}
a= 50
b = 5
c = 25
d = 4.09
EC3= 2^ {log2(25) + (3-4.09)/(5-4.09)] x [log2(50)-log2(25)]}
The concentration of test material expected to cause a 3 fold increase in3HTdR incorporation (extrapolated EC3value) was calculated to be 10.9%.a= middle concentration giving a stimulation index >3
b = actual stimulation index caused by a
c = lowest concentration giving a stimulation index of >3
d = actual stimulation index caused by c
Table1 Clinical Observations, Bodyweight and Mortality Data – Preliminary Screening Test
Concentration |
Animal Number |
Bodyweight (g) |
Day |
||||||||||||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
||||||||||||||||||||
Day 1 |
Day 6 |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
||||||||||||||||||
100% |
S-1 |
18 |
18 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Table2 Individual Disintegrations per Minute and Stimulation Indices
Concentration |
Animal Number |
dpm/ |
Mean dpm/Animal |
Stimulation Indexb |
Result |
Vehicle |
1-1 |
2457.06 |
1998.59 |
N/A |
N/A |
1-2 |
2001.58 |
||||
1-3 |
1656.20 |
||||
1-4 |
2853.11 |
||||
1-5 |
1024.98 |
||||
25 |
2-1 |
12453.04 |
8181.37 |
4.09 |
Positive |
2-2 |
2308.30 |
||||
2-3 |
11160.93 |
||||
2-4 |
4436.91 |
||||
2-5 |
10547.65 |
||||
50 |
3-1 |
11442.35 |
9989.32** |
5.00 |
Positive |
3-2 |
11810.86 |
||||
3-3 |
8533.27 |
||||
3-4 |
11877.56 |
||||
3-5 |
6282.57 |
||||
100 |
4-1 |
18148.28 |
13558.00** |
6.78 |
Positive |
4-2 |
12422.15 |
||||
4-3 |
9516.08 |
||||
4-4 |
13021.79 |
||||
4-5 |
14681.72 |
Table3 Individual Clinical Observations and Mortality Data
Concentration |
Animal Number |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
||||||||||||||
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
||||||||||||||||
Vehicle |
1-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|||||||||||
1-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
1-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
1-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
1-5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
25 |
2-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|||||||||||
2-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
2-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
2-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
2-5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
50 |
3-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|||||||||||
3-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
3-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
3-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
3-5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
100 |
4-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|||||||||||
4-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
4-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
4-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||||
4-5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Table4 Individual Bodyweights and Bodyweight Changes
Concentration |
Animal Number |
Bodyweight (g) |
Bodyweight Change (g) |
||||||
Day 1 |
Day 6 |
||||||||
Vehicle |
1-1 |
16 |
18 |
2 |
|||||
1-2 |
19 |
20 |
1 |
||||||
1-3 |
21 |
22 |
1 |
||||||
1-4 |
19 |
19 |
0 |
||||||
1-5 |
18 |
19 |
1 |
||||||
25 |
2-1 |
18 |
18 |
0 |
|||||
2-2 |
19 |
19 |
0 |
||||||
2-3 |
21 |
22 |
1 |
||||||
2-4 |
19 |
19 |
0 |
||||||
2-5 |
18 |
19 |
1 |
||||||
50 |
3-1 |
20 |
19 |
-1 |
|||||
3-2 |
19 |
19 |
0 |
||||||
3-3 |
19 |
20 |
1 |
||||||
3-4 |
18 |
18 |
0 |
||||||
3-5 |
18 |
19 |
1 |
||||||
100 |
4-1 |
18 |
19 |
1 |
|||||
4-2 |
19 |
20 |
1 |
||||||
4-3 |
19 |
19 |
0 |
||||||
4-4 |
19 |
19 |
0 |
||||||
4-5 |
18 |
19 |
1 |
Appendix1 Current Positive Control Study for the Local Lymph Node Assay
Introduction. A study was performed to assess the sensitivity of the strain of mouse used at these laboratories to a known sensitiser. The methodology for the LLNA is detailed in the OECD Guideline for the Testing of Chemicals, No. 429, and Method B.42 of CommissionRegulation (EC) No. 440/2008. The study described in this document is based on these test methods but has been refined in order to reduce the number of animals required. The reduced LLNA (rLLNA) has been endorsed by the non‑Commission members of the European Centre for the Validation of Alternative Method (ECVAM) Scientific Advisory Committee (ESAC) at its 26thmeeting held on 26 – 27 April 2007 at ECVAM,,.
Test Material: α‑Hexylcinnamaldehyde
Project number: 0039/1107
Study dates: 11 September 2009 to 17 September 2009
Methods. A group of five animals was treated with 50 µl (25 µl per ear) ofα‑Hexylcinnamaldehydeas a solution in acetone/olive oil 4:1at a concentration of 15% v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone. The control group was shared with Project Number 0673/0012.
Results. The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group is as follows:
Concentration (% v/v) in |
Stimulation Index |
Result |
|||
15 |
3.70 |
Positive |
Conclusion. α‑Hexylcinnamaldehydewas considered to be a sensitiser under the conditions of the test.
Appendix2 Summary of Positive Control Data for the Local Lymph Node Assay
Project Number |
Start Date |
Finish Date |
Test Material |
Concentration |
Vehicle |
Stimulation Indexa |
Classificationb |
||||||||
0039/1061 |
05/11/08 |
11/11/08 |
α‑Hexylcinnamaldehyde |
15% v/v |
acetone |
4.21 |
Positive |
||||||||
0039/1062 |
05/11/08 |
11/11/08 |
α‑Hexylcinnamaldehyde |
15% v/v |
ethanol/distilled water 7:3 |
9.49 |
Positive |
||||||||
0039/1078 |
18/03/09 |
24/03/09 |
2,4-Dinitrobenzenesulfonic acid, sodium salt |
10% w/w |
1% pluronic L92 |
13.71 |
Positive |
||||||||
0039/1079 |
20/03/09 |
26/03/09 |
Phenylacetaldehyde (90%) |
2.5% v/v |
propylene glycol |
8.00 |
Positive |
||||||||
0039/1080 |
24/04/09 |
30/04/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
acetone/olive oil 4:1 |
8.34 |
Positive |
||||||||
0039/1081 |
30/04/09 |
06/05/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
dimethyl formamide |
4.24 |
Positive |
||||||||
0039/1082 |
17/04/09 |
23/04/09 |
α‑Hexylcinnamaldehyde |
50% v/v |
cotton seed oil |
6.54 |
Positive |
||||||||
0039/1083 |
16/04/09 |
22/04/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
butanone |
4.08 |
Positive |
||||||||
0039/1084 |
17/04/09 |
23/04/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
dimethyl sulphoxide |
4.60 |
Positive |
||||||||
0039/1091 |
25/06/09 |
01/07/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
ethanol/distilled water 7:3 |
10.68 |
Positive |
||||||||
0039/1092 |
25/06/09 |
01/07/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
acetone |
10.72 |
Positive |
||||||||
0039/1099 |
08/07/09 |
14/07/09 |
α‑Hexylcinnamaldehyde |
5%, 10% 25% v/v |
1% pluronic L92 |
1.30, 2.37, 8.14 |
Positive |
||||||||
0039/1107 |
11/09/09 |
17/09/09 |
α‑Hexylcinnamaldehyde |
15% v/v |
acetone/olive oil 4:1 |
3.70 |
Positive |
||||||||
0039/1108 |
01/107/09 |
07/10/09 |
α‑Hexylcinnamaldehyde |
25% v/v |
1% pluronic L92 |
5.11 |
Positive |
Appendix3 Vehicle Determination Record
Vehicle |
Concentration |
Method of Preparation |
Description of Formulation |
Suitability* |
acetone/olive oil (4:1) |
50% |
Vortex mixer |
solution |
suitable for dosing |
0= No signs of systemic toxicity
dpm=Disintegrations per minute
a= Total number of lymph nodes per animal is 2
b= Stimulation Index of 3.0 or greater indicates a positive result
N/A= Not applicable
**= Significantly different from control group p<0.01
0= No signs of systemic toxicity
a= Ratio of test to control lymphocyte proliferation
b= Stimulation index greater than 3.0 indicates a positive result
*= Suitable for dosing if formulation is a solution or fine homogenous suspension which can be administered via a micropipette
Interpretation of Results
The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph nodes from each individual animal and as the ratio of3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index).
The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in3HTdR incorporation will be classified as a "non-sensitiser".
The results were evaluated according to Commission Directive 2001/59/EC for classification and labelling of dangerous substances.
For chemicals, which the lowest concentration tested resulted in a stimulation index of greater than 3, an EC3value was extrapolated from the two lowest doses utilized. The extrapolated EC3value was calculated by log-linear interpolation between the two points on a plane where thec-axis represents the dose level and theg‑axis represents the SI (Stimulation Index). The point with the higher SI was denoted (a, b) and the point with the lower SI was denoted (c, d). The formula for the extrapolated EC3value was as follows:
aEC3= 2^ {log2(c) + (3-d)/(b-d)] x [log2(a)-log2(c)]}
a= middle concentration giving a stimulation index >3
b = actual stimulation index caused by a
c = lowest concentration giving a stimulation index of >3
d = actual stimulation index caused by c
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test material was considered to be a weak sensitiser under the conditions of the test. SI was 4.09, 5.00, and 6.78 at 25, 50, and 100%, respectively.
- Executive summary:
Introduction.
A study was performed to assess the skin sensitisation potential of the test material in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was designed to meet the requirements of the following:
§ OECD Guideline for the Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay" (adopted 24 April 2002)
§ Method B42 Skin Sensitisation (Local Lymph Node Assay) of CommissionRegulation (EC) No. 440/2008
Methods.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 100%, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of five animals, were treated with 50 µL (25 µL per ear) of the undiluted test material or the test material as a solution in acetone/olive oil 4:1 at concentrations of 50% or 25% v/v. A further group of five animals was treated with acetone/olive oil 4:1 alone.
Results.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (%v/v) in
acetone/olive oil 4:1Stimulation Index
Result
25
4.09
Positive
50
5.00
Positive
100
6.78
Positive
The concentration of test material expected to cause a 3 fold increase in3HTdR incorporation (EC3value) was calculated to be 10.9%.
Conclusion.
The test material was considered to be a weak sensitiser under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.